270 related articles for article (PubMed ID: 23721146)
1. MRI patterns of T1 enhancing radiation necrosis versus tumour recurrence in high-grade gliomas.
Reddy K; Westerly D; Chen C
J Med Imaging Radiat Oncol; 2013 Jun; 57(3):349-55. PubMed ID: 23721146
[TBL] [Abstract][Full Text] [Related]
2. Glioma recurrence versus radiation necrosis? A pilot comparison of arterial spin-labeled, dynamic susceptibility contrast enhanced MRI, and FDG-PET imaging.
Ozsunar Y; Mullins ME; Kwong K; Hochberg FH; Ament C; Schaefer PW; Gonzalez RG; Lev MH
Acad Radiol; 2010 Mar; 17(3):282-90. PubMed ID: 20060750
[TBL] [Abstract][Full Text] [Related]
3. Treatment-related change versus tumor recurrence in high-grade gliomas: a diagnostic conundrum--use of dynamic susceptibility contrast-enhanced (DSC) perfusion MRI.
Fatterpekar GM; Galheigo D; Narayana A; Johnson G; Knopp E
AJR Am J Roentgenol; 2012 Jan; 198(1):19-26. PubMed ID: 22194475
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of dynamic contrast-enhanced T1-weighted perfusion MRI in the differentiation of tumor recurrence from radiation necrosis.
Larsen VA; Simonsen HJ; Law I; Larsson HB; Hansen AE
Neuroradiology; 2013 Feb; 55(3):361-9. PubMed ID: 23262559
[TBL] [Abstract][Full Text] [Related]
5. Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI.
Fayed N; Dávila J; Medrano J; Olmos S
Eur J Radiol; 2008 Sep; 67(3):427-33. PubMed ID: 18442889
[TBL] [Abstract][Full Text] [Related]
6. Distinction between postoperative recurrent glioma and delayed radiation injury using MR perfusion weighted imaging.
Xu JL; Shi DP; Dou SW; Li YL; Yan FS
J Med Imaging Radiat Oncol; 2011 Dec; 55(6):587-94. PubMed ID: 22141606
[TBL] [Abstract][Full Text] [Related]
7. Radiation necrosis or glioma recurrence: is computer-assisted stereotactic biopsy useful?
Forsyth PA; Kelly PJ; Cascino TL; Scheithauer BW; Shaw EG; Dinapoli RP; Atkinson EJ
J Neurosurg; 1995 Mar; 82(3):436-44. PubMed ID: 7861222
[TBL] [Abstract][Full Text] [Related]
8. Differentiation between brain tumor recurrence and radiation injury using perfusion, diffusion-weighted imaging and MR spectroscopy.
Bobek-Billewicz B; Stasik-Pres G; Majchrzak H; Zarudzki L
Folia Neuropathol; 2010; 48(2):81-92. PubMed ID: 20602289
[TBL] [Abstract][Full Text] [Related]
9. Radiation necrosis in the brain: imaging features and differentiation from tumor recurrence.
Shah R; Vattoth S; Jacob R; Manzil FF; O'Malley JP; Borghei P; Patel BN; Curé JK
Radiographics; 2012; 32(5):1343-59. PubMed ID: 22977022
[TBL] [Abstract][Full Text] [Related]
10. Can standard magnetic resonance imaging reliably distinguish recurrent tumor from radiation necrosis after radiosurgery for brain metastases? A radiographic-pathological study.
Dequesada IM; Quisling RG; Yachnis A; Friedman WA
Neurosurgery; 2008 Nov; 63(5):898-903; discussion 904. PubMed ID: 19005380
[TBL] [Abstract][Full Text] [Related]
11. Patterns of failure after concurrent bevacizumab and hypofractionated stereotactic radiation therapy for recurrent high-grade glioma.
Shapiro LQ; Beal K; Goenka A; Karimi S; Iwamoto FM; Yamada Y; Zhang Z; Lassman AB; Abrey LE; Gutin PH
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):636-42. PubMed ID: 22765876
[TBL] [Abstract][Full Text] [Related]
12. Progress in neuro-oncology: imaging in-phase!
Cottier JP
Diagn Interv Imaging; 2014 Oct; 95(10):905. PubMed ID: 25288181
[No Abstract] [Full Text] [Related]
13. [Brain MR perfusion and MR spectroscopy in differentiation of radiation necrosis from tumor recurrence (case report)].
Tekşam M; Kayahan EM; Yerli H; Ağildere AM
Tani Girisim Radyol; 2004 Dec; 10(4):263-7. PubMed ID: 15611913
[TBL] [Abstract][Full Text] [Related]
14. Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment.
Kumar AJ; Leeds NE; Fuller GN; Van Tassel P; Maor MH; Sawaya RE; Levin VA
Radiology; 2000 Nov; 217(2):377-84. PubMed ID: 11058631
[TBL] [Abstract][Full Text] [Related]
15. Comparison of diffusion tensor, dynamic susceptibility contrast MRI and (99m)Tc-Tetrofosmin brain SPECT for the detection of recurrent high-grade glioma.
Alexiou GA; Zikou A; Tsiouris S; Goussia A; Kosta P; Papadopoulos A; Voulgaris S; Tsekeris P; Kyritsis AP; Fotopoulos AD; Argyropoulou MI
Magn Reson Imaging; 2014 Sep; 32(7):854-9. PubMed ID: 24848292
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of contrast-enhancing low-grade gliomas in adults and a review of the literature.
Chaichana KL; McGirt MJ; Niranjan A; Olivi A; Burger PC; Quinones-Hinojosa A
Neurol Res; 2009 Nov; 31(9):931-9. PubMed ID: 19215664
[TBL] [Abstract][Full Text] [Related]
17. Contrast/Noise ratio on conventional MRI and choline/creatine ratio on proton MRI spectroscopy accurately discriminate low-grade from high-grade cerebral gliomas.
Fayed N; Morales H; Modrego PJ; Pina MA
Acad Radiol; 2006 Jun; 13(6):728-37. PubMed ID: 16679275
[TBL] [Abstract][Full Text] [Related]
18. Application value of apparent diffusion coefficient in differentiation of brain radiation-injuries and glioma recurrence.
Wang YL; Liu MY; Li JF; Zhang J; Sun L; Feng F; Ma L
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Aug; 34(4):396-400. PubMed ID: 22954125
[TBL] [Abstract][Full Text] [Related]
19. Posttreatment high-grade glioma: usefulness of peak height position with semiquantitative MR perfusion histogram analysis in an entire contrast-enhanced lesion for predicting volume fraction of recurrence.
Kim HS; Kim JH; Kim SH; Cho KG; Kim SY
Radiology; 2010 Sep; 256(3):906-15. PubMed ID: 20634429
[TBL] [Abstract][Full Text] [Related]
20. Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging.
Zeng QS; Li CF; Liu H; Zhen JH; Feng DC
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):151-8. PubMed ID: 17289287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
